BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30031117)

  • 1. Genome-wide identification of transcription factors that are critical to non-small cell lung cancer.
    Zhang DL; Qu LW; Ma L; Zhou YC; Wang GZ; Zhao XC; Zhang C; Zhang YF; Wang M; Zhang MY; Yu H; Sun BB; Gao SH; Cheng X; Guo MZ; Huang YC; Zhou GB
    Cancer Lett; 2018 Oct; 434():132-143. PubMed ID: 30031117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of stretch-activated channels, PIEZOs, accelerates non-small cell lung cancer progression and cell migration.
    Huang Z; Sun Z; Zhang X; Niu K; Wang Y; Zheng J; Li H; Liu Y
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30745454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer.
    Zhao H; Wang J; Kong X; Li E; Liu Y; Du X; Kang Z; Tang Y; Kuang Y; Yang Z; Zhou Y; Wang Q
    Sci Rep; 2016 Jul; 6():29719. PubMed ID: 27411490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly Expressed FOXF1 Inhibit Non-Small-Cell Lung Cancer Growth via Inducing Tumor Suppressor and G1-Phase Cell-Cycle Arrest.
    Wu CY; Chan CH; Dubey NK; Wei HJ; Lu JH; Chang CC; Cheng HC; Ou KL; Deng WP
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32370197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentivirus-delivered ZEB-1 small interfering RNA inhibits lung adenocarcinoma cell growth in vitro and in vivo.
    Liu Y; Yan X; Liu N; Zhou J; Liu J; Pang H; Cao J; Liu Y; Wang Y; Liu L; Zhang H
    J Cancer Res Clin Oncol; 2012 Aug; 138(8):1329-38. PubMed ID: 22481253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. piR-651 promotes tumor formation in non-small cell lung carcinoma through the upregulation of cyclin D1 and CDK4.
    Li D; Luo Y; Gao Y; Yang Y; Wang Y; Xu Y; Tan S; Zhang Y; Duan J; Yang Y
    Int J Mol Med; 2016 Sep; 38(3):927-36. PubMed ID: 27431575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiroRNA-188 Acts as Tumor Suppressor in Non-Small-Cell Lung Cancer by Targeting MAP3K3.
    Zhao L; Ni X; Zhao L; Zhang Y; Jin D; Yin W; Wang D; Zhang W
    Mol Pharm; 2018 Apr; 15(4):1682-1689. PubMed ID: 29528232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of TGIF attenuates the tumorigenicity of A549 cells in vitro and in vivo.
    Wang Y; Pan T; Wang H; Li L; Li J; Zhang C; Yang H
    Tumour Biol; 2016 Sep; 37(9):12725-12730. PubMed ID: 27448304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting stemness is an effective strategy to control EML4-ALK+ non-small cell lung cancer cells.
    Oh SJ; Noh KH; Lee YH; Hong SO; Song KH; Lee HJ; Kim S; Kim TM; Jeon JH; Seo JH; Kim DW; Kim TW
    Oncotarget; 2015 Nov; 6(37):40255-67. PubMed ID: 26517679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN.
    Xue X; Liu Y; Wang Y; Meng M; Wang K; Zang X; Zhao S; Sun X; Cui L; Pan L; Liu S
    Oncotarget; 2016 Dec; 7(51):84508-84519. PubMed ID: 27811366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer.
    Cai WK; Hu J; Li T; Meng JR; Ma X; Yin SJ; Zhao CH; He GH; Xu GL
    Eur J Cancer; 2014 Apr; 50(6):1195-206. PubMed ID: 24447834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BHLHE40 confers a pro-survival and pro-metastatic phenotype to breast cancer cells by modulating HBEGF secretion.
    Sethuraman A; Brown M; Krutilina R; Wu ZH; Seagroves TN; Pfeffer LM; Fan M
    Breast Cancer Res; 2018 Oct; 20(1):117. PubMed ID: 30285805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDM2 knockdown mediated by a triazine-modified dendrimer in the treatment of non-small cell lung cancer.
    Huang Q; Li L; Li L; Chen H; Dang Y; Zhang J; Shao N; Chang H; Zhou Z; Liu C; He B; Wei H; Xiao J
    Oncotarget; 2016 Jul; 7(28):44013-44022. PubMed ID: 27259273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of ELF3 facilitates cell growth and metastasis through PI3K/Akt and ERK signaling pathways in non-small cell lung cancer.
    Wang H; Yu Z; Huo S; Chen Z; Ou Z; Mai J; Ding S; Zhang J
    Int J Biochem Cell Biol; 2018 Jan; 94():98-106. PubMed ID: 29208568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and therapeutic impact of RPN2-mediated tumor malignancy in non-small-cell lung cancer.
    Fujita Y; Yagishita S; Takeshita F; Yamamoto Y; Kuwano K; Ochiya T
    Oncotarget; 2015 Feb; 6(5):3335-45. PubMed ID: 25595901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Noncoding RNA Colorectal Neoplasia Differentially Expressed Gene as a Potential Target to Upregulate the Expression of IRX5 by miR-136-5P to Promote Oncogenic Properties in Hepatocellular Carcinoma.
    Zhu L; Liu Y; Chen Q; Yu G; Chen J; Chen K; Yang N; Zeng T; Yan S; Huang A; Tang H
    Cell Physiol Biochem; 2018; 50(6):2229-2248. PubMed ID: 30423553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of RalA signaling pathway in treatment of non-small cell lung cancer.
    Male H; Patel V; Jacob MA; Borrego-Diaz E; Wang K; Young DA; Wise AL; Huang C; Van Veldhuizen P; O'Brien-Ladner A; Williamson SK; Taylor SA; Tawfik O; Esfandyari T; Farassati F
    Lung Cancer; 2012 Aug; 77(2):252-9. PubMed ID: 22498113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-19a functions as an oncogenic microRNA in non-small cell lung cancer by targeting the suppressor of cytokine signaling 1 and mediating STAT3 activation.
    Wang X; Chen Z
    Int J Mol Med; 2015 Mar; 35(3):839-46. PubMed ID: 25604748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.